Evaluación de la eficacia del haloperidol decanoato en el tratamiento de pacientes psicóticas crónicas hospitalizadas. / [Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients]

ABSTRACT

The purpose of our experience was to determine the efficacy of haloperidol decanoate during the treatment of chronic psychotic in-patients. So we included, in an open study, 30 patients hospitalized in the Esquirol and Magnan Departments of the National Hospital of Mental Health [quot ]Dr. Braulio A. Moyano[quot ]. As a result of this study, we have observed that to the already known properties of this drug, it may be added, because of its new depot formulation, the following advantages a) it replaces effectively the daily intake of neuroleptics; b) it allows the reduction of the dose of oral neuroleptics as well as the number of drugs combination; c) it diminishes the incidence of extrapyramidal symptoms, allowing the reduction of the dose or the interruption of antiparkinsonian drugs; d) it facilitates the nurses labor; e) it allows the physician to be sure of the fulfillment of his prescription.